Class information for:
Level 2: MYC//MAX//C MYC

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
2754 3201 47.7 84%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
373 3       ENDOGENOUS RETROVIRUS//VIROLOGY//JOURNAL OF VIROLOGY 32972
2754 2             MYC//MAX//C MYC 3201
1198 1                   MYC//MAX//C MYC 2790
26623 1                   PRISTANE//PLASMACYTOMAGENESIS//ABL MYC 250
30887 1                   ANIM EXPERIMENTS//ASCITES METHOD//ASCITES TUMOUR FLUID 161

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MYC authKW 475667 7% 21% 240
2 MAX authKW 367627 2% 48% 80
3 C MYC authKW 365489 10% 12% 314
4 MXI1 authKW 112189 1% 59% 20
5 PRISTANE authKW 83043 1% 31% 28
6 MNT authKW 67044 0% 47% 15
7 MAD authKW 53483 1% 17% 33
8 ONCOGENE journal 49672 10% 2% 307
9 10058 F4 authKW 49048 0% 86% 6
10 10074 G5 authKW 47687 0% 100% 5

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 Cell Biology 22975 43% 0% 1389
2 Oncology 11781 32% 0% 1032
3 Biochemistry & Molecular Biology 8261 43% 0% 1384
4 Genetics & Heredity 5249 18% 0% 570
5 Immunology 947 10% 0% 319
6 Biology 827 5% 0% 167
7 Developmental Biology 718 3% 0% 108
8 Hematology 175 3% 0% 99
9 Medicine, Research & Experimental 147 4% 0% 120
10 Virology 140 2% 0% 68

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 TR ON 28612 0% 100% 3
2 MOL BIOL TUMOUR 19864 0% 42% 5
3 BIOL RUMENTAT PROGRAMME 19075 0% 100% 2
4 CELL BIOL HUMAN ANAT MED 19075 0% 100% 2
5 CELLULAR MOL BIOL GENET 19075 0% 100% 2
6 ROCHE PHARMA PENZBERG 19075 0% 100% 2
7 THURSTON ARTHRIT 3330 19075 0% 100% 2
8 WM KECK PROTEOM 12715 0% 67% 2
9 WOLFSON MOL PATHOL 12715 0% 67% 2
10 GENOM SCI IIT SEMM 11515 0% 13% 9

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ONCOGENE 49672 10% 2% 307
2 CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 42754 4% 4% 124
3 ONCOGENE RESEARCH 17525 1% 10% 18
4 MOLECULAR AND CELLULAR BIOLOGY 16771 6% 1% 199
5 EKSPERIMENTALNAYA ONKOLOGIYA 7355 1% 3% 31
6 COLD SPRING HARBOR PERSPECTIVES IN MEDICINE 7174 1% 4% 21
7 GENES & DEVELOPMENT 3929 2% 1% 56
8 CELL GROWTH & DIFFERENTIATION 3860 1% 2% 24
9 EMBO JOURNAL 3625 3% 0% 82
10 CANCER RESEARCH 2535 3% 0% 105

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 MYC 475667 7% 21% 240 Search MYC Search MYC
2 MAX 367627 2% 48% 80 Search MAX Search MAX
3 C MYC 365489 10% 12% 314 Search C+MYC Search C+MYC
4 MXI1 112189 1% 59% 20 Search MXI1 Search MXI1
5 PRISTANE 83043 1% 31% 28 Search PRISTANE Search PRISTANE
6 MNT 67044 0% 47% 15 Search MNT Search MNT
7 MAD 53483 1% 17% 33 Search MAD Search MAD
8 10058 F4 49048 0% 86% 6 Search 10058+F4 Search 10058+F4
9 10074 G5 47687 0% 100% 5 Search 10074+G5 Search 10074+G5
10 B HLH LZ 47687 0% 100% 5 Search B+HLH+LZ Search B+HLH+LZ

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 MEYER, N , PENN, LZ , (2008) MYC - TIMELINE REFLECTING ON 25 YEARS WITH MYC.NATURE REVIEWS CANCER. VOL. 8. ISSUE 12. P. 976 -990 187 67% 565
2 GRANDORI, C , COWLEY, SM , JAMES, LP , EISENMAN, RN , (2000) THE MYC/MAX/MAD NETWORK AND THE TRANSCRIPTIONAL CONTROL OF CELL BEHAVIOR.ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY. VOL. 16. ISSUE . P. 653 -699 188 66% 760
3 MARCU, KB , BOSSONE, SA , PATEL, AJ , (1992) MYC FUNCTION AND REGULATION.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 61. ISSUE . P. 809 -860 252 61% 767
4 LITTLEWOOD, TD , EVAN, GI , (1995) TRANSCRIPTION FACTORS .2. HELIX-LOOP-HELIX.PROTEIN PROFILE. VOL. 2. ISSUE 6. P. 621 -702 515 43% 88
5 LITTLEWOOD, TD , EVAN, GI , (1994) TRANSCRIPTION FACTORS-2 - HELIX-LOOP-HELIX.PROTEIN PROFILE. VOL. 1. ISSUE 6. P. 639-709 502 48% 36
6 HENRIKSSON, M , LUSCHER, B , (1996) PROTEINS OF THE MYC NETWORK: ESSENTIAL REGULATORS OF CELL GROWTH AND DIFFERENTIATION.ADVANCES IN CANCER RESEARCH, VOL 68. VOL. 68. ISSUE . P. 109-182 227 55% 569
7 DANG, CV , (1999) C-MYC TARGET GENES INVOLVED IN CELL GROWTH, APOPTOSIS, AND METABOLISM.MOLECULAR AND CELLULAR BIOLOGY. VOL. 19. ISSUE 1. P. 1-11 134 69% 925
8 DANG, CV , (2012) MYC ON THE PATH TO CANCER.CELL. VOL. 149. ISSUE 1. P. 22-35 101 47% 570
9 CONACCI-SORRELL, M , MCFERRIN, L , EISENMAN, RN , (2014) AN OVERVIEW OF MYC AND ITS INTERACTOME.COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. VOL. 4. ISSUE 1. P. - 147 68% 18
10 DIOLAITI, D , MCFERRIN, L , CARROLL, PA , EISENMAN, RN , (2015) FUNCTIONAL INTERACTIONS AMONG MEMBERS OF THE MAX AND MLX TRANSCRIPTIONAL NETWORK DURING ONCOGENESIS.BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS. VOL. 1849. ISSUE 5. P. 484 -500 148 57% 6

Classes with closest relation at Level 2



Rank Class id link
1 1143 GENOMICS//CYTOGENETICS AND CELL GENETICS//MINISATELLITE
2 4146 PIM KINASE//PIM 1//PIM 2
3 2228 C MYB//B MYB//SRC
4 1899 NEUROBLASTOMA//ALVEOLAR SOFT PART SARCOMA//MYCN
5 1709 C FOS//EGR 1//IMMEDIATE EARLY GENE
6 2713 METHYLSULFONYLMETHANE//SEROFENDIC ACID//N ACETYL S N METHYLCARBAMOYLCYSTEINE
7 3833 CITED2//BRANCHIO OCULO FACIAL SYNDROME//AP 2 ALPHA
8 3175 ID 1//NRSF//ID1
9 483 CYCLIN DEPENDENT KINASE//CELL CYCLE//CDK5
10 2612 WARBURG EFFECT//PKM2//PYRUVATE KINASE

Go to start page